1887

Abstract

Characterization of a tissue culture-adapted strain of murine cytomegalovirus (MCMV), the Vancouver strain, which demonstrated altered tissue tropism in mice was undertaken to help understand the mechanism of pathogenesis of cytomegaloviruses. The Vancouver strain grew to a limited extent in the spleen but failed to grow in the salivary glands of inoculated mice. This mutation probably arose during multiple passaging of the parental Smith strain. The Vancouver strain replicated more quickly and produced a greater yield of virus per cycle than the Smith strain , resulting in a larger plaque size. In addition to these phenotypic differences, the Vancouver strain was found to have a 9.4 kb deletion spanning the I I/L junction of the parental Smith strain (0.960 to 0.995 map units), and a 0.9 kb insertion which mapped to the RI K fragment (0.37 to 0.47 map units). Analysis of virus-induced proteins at various times post-infection identified only one major change in Vancouver strain-infected cells, the absence of a 42K protein found in Smith-infected cells at early and late times.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-8-2021
1992-08-01
2024-05-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/8/JV0730082021.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-8-2021&mimeType=html&fmt=ahah

References

  1. Baskar J. F., Stanat S. C., Huang E. S. 1983; Cytomegalovirus infection of murine testicular interstitial Leydig cells. Infection and Immunity 40:726–732
    [Google Scholar]
  2. Cheung K. S., Lang D. J. 1977; Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infection and Immunity 15:568–575
    [Google Scholar]
  3. Ebeling A., Keil G. M., Knust E., Koszinowski U. H. 1983; Molecular cloning and physical mapping of murine cytomegalovirus DNA. Journal of Virology 47:421–433
    [Google Scholar]
  4. Griffiths P. D., Grundy J. E. 1987; Molecular biology and immunology of cytomegalovirus. Biochemical Journal 241:313–324
    [Google Scholar]
  5. Ho M. 1982 Cytomegalovirus, Biology and Infection New York: Plenum Press;
    [Google Scholar]
  6. Hodgkin P. D., Scalzo A. A., Swaminathan N., Price P., Shellam G. R. 1988; Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implication for quantitation and explanation of centrifugal enhancement. Journal of Virological Methods 22:215–230
    [Google Scholar]
  7. Hudson J. B. 1979; The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62:1–29
    [Google Scholar]
  8. Koszinowski U. H., Reddehase M. J., Keil G. M., Volkmer H., Jonjic S., Messerle M., del Val M., Mutter W., Munch K., Buhler B. 1987a; Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunology Letters 16:185–192
    [Google Scholar]
  9. Koszinowski U. H., Reddehase M. J., Keil G. M., Schickedanz J. 1987b; Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes. Journal of Virology 61:2054–2058
    [Google Scholar]
  10. Kumura K., Ibusuki K., Minamishima Y. 1990; Independent existence of mutations responsible for temperature sensitivity and attenuation in a mutant of murine cytomegalovirus. Virology 175:572–574
    [Google Scholar]
  11. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  12. McCordock H. A., Smith M. G. 1936; The visceral lesions produced in mice by the salivary gland virus of mice. Journal of Experimental Medicine 63:303–310
    [Google Scholar]
  13. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  14. Manning W. C., Stoddart C. A., Lagenaur L. A., Abenes G. B., Mocarski E. S. 1992; Cytomegalovirus determinant of replication in salivary glands. Journal of Virology 66:3794–3802
    [Google Scholar]
  15. Medearis D. N. 1964; Mouse cytomegalovirus infection. II. Observations during prolonged infection. American Journal of Hygiene 80:103–112
    [Google Scholar]
  16. Mercer J. A., Marks J. R., Spector D. H. 1983; Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome. Virology 129:94–106
    [Google Scholar]
  17. Mims C. A., Gould J. 1979; Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus. Journal of Medical Microbiology 12:113–122
    [Google Scholar]
  18. Osborn J. E., Walker D. L. 1970; Virulence and attenuation of murine cytomegalovirus. Infection and Immunity 3:228–236
    [Google Scholar]
  19. Plummer G. 1973; Cytomegaloviruses of man and animals. Progress in Medical Virology 15:92–125
    [Google Scholar]
  20. Ravindranath R. M. H., Graves M. C. 1990; Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids. Journal of Virology 64:5430–5440
    [Google Scholar]
  21. Reddehase M. J., Fibi M. R., Keil G. M., Koszinowski U. H. 1986; Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. Journal of Virology 60:1125–1129
    [Google Scholar]
  22. Sandford G. R., Burns W. H. 1988; Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines. Journal of Infectious Diseases 158:596–601
    [Google Scholar]
  23. Selgrade M. K., Nedrud J. G., Collier A. M., Gardner D. E. 1981; Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus. Infection and Immunity 33:840–847
    [Google Scholar]
  24. Southern E. M. 1979; Gel electrophoresis of restriction fragments. Methods in Enzymology 68:152–176
    [Google Scholar]
  25. Tonari U., Minamishima Y. 1983; Pathogenicity and immunogenicity of temperature-sensitive mutants of murine cytomegalovirus. Journal of General Virology 64:1983–1990
    [Google Scholar]
  26. Weller T. H. 1971; The cytomegaloviruses: ubiquitous agents with protean clinical manifestations (first of two parts). New England Journal of Medicine 285203–214
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-8-2021
Loading
/content/journal/jgv/10.1099/0022-1317-73-8-2021
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error